Neocep Dry Syrup 125 mg/5 mL (Cefaclor Hydrate)
Cefaclor Hydrate 3.75g
Syrup · Prescription medication
Jinyang Pharmaceutical Co., Ltd.
MFDS item code 199601169 · Notified 1996.05.08 · Insurance code 650300161
Treatment of otitis media, respiratory infections (pneumonia, pharyngitis, etc.), urinary tract infections (pyelonephritis, cystitis, etc.)
This medicine is effective against a variety of harmful bacteria, including Streptococcus pneumoniae, Influenza bacillus, and Staphylococcus. It is used to treat respiratory infections such as otitis media, pneumonia, pharyngitis, tonsillitis, and bronchitis. It is also effective for urinary tract infections such as pyelonephritis, cystitis, and gonococcal urethritis, as well as for skin and soft tissue infections such as furuncles, cellulitis, and wound infections. This medication is widely used for infectious diseases to improve symptoms and aid recovery.
Adult: Administer 250 mg (based on potency) of cefaclor orally every 8 hours. In cases of severe infections (such as pneumonia) and infections with low susceptibility, the dose can be doubled. For acute gonococcal urethritis, a single dose of 3 g of this drug and 1 g of probenecid are administered together.
Pediatric: Administer 20 mg (based on potency) per kg of body weight daily, divided every 8 hours. In cases of severe infections, otitis media, and infections with low susceptibility, 40 mg (based on potency) per kg of body weight daily may be administered.
This drug acts by binding to specific proteins and interfering with bacterial cell wall synthesis, killing the bacteria. This medication should not be used in patients who have previously experienced severe allergic reactions or shock due to this medication or other cephalosporin antibiotics. Caution should be taken when using in patients with a history of allergy to penicillin antibiotics or those who easily develop allergic symptoms such as bronchial asthma, rash, or urticaria. Patients with significantly impaired renal function, those unable to take orally, elderly patients, or those with poor general conditions may show signs of vitamin K deficiency, and therefore should be carefully monitored. Patients with gastrointestinal diseases, especially those with a history of colitis, should be cautious when using this medication. During use, rare occurrences of shock or severe allergic reactions may occur, so if symptoms appear, discontinue use immediately and seek appropriate treatment. Severe reactions such as Stevens-Johnson syndrome or toxic epidermal necrolysis may occur, so careful observation of the skin condition is necessary. Blood tests may show abnormalities such as leukopenia, thrombocytopenia, or anemia, so regular monitoring is required; if abnormalities are found, discontinue use of the drug. Symptoms of liver dysfunction or renal impairment may emerge, requiring regular monitoring of liver and kidney functions, and immediate action if abnormalities are noted. Severe colitis, such as membranous colitis, can rarely occur, so if abdominal pain or diarrhea worsens, discontinue use immediately. Respiratory symptoms or interstitial pneumonia may occur, so in cases of cough or difficulty breathing, consult medical personnel promptly. This medication may affect the central nervous system leading to restlessness, anxiety, dizziness, hallucinations, or drowsiness; monitoring is required if these symptoms arise. Oral conditions should be observed since disruptions such as oral inflammation or candidiasis may occur. There may be a risk of bleeding tendency or deficiency symptoms of vitamin B complex due to vitamin K deficiency; thus, vigilance over bleeding symptoms or neurological symptoms is necessary. Interactions may occur when used with other medications, particularly those affecting the kidneys, anticoagulants, or oral contraceptives; caution is advised in these cases. The safety of this medication during pregnancy has not been established, so it should only be used cautiously when necessary, and those who are breastfeeding should also be aware that small amounts of the drug may pass into breast milk. For newborns under 1 month, safety and efficacy have not been confirmed; therefore, it is recommended not to use it. In elderly patients, adverse reactions can occur more easily due to diminished physiological functions, so dose adjustments and monitoring of condition are essential. When using this medication, it is advisable to confirm susceptibility and administer only for the necessary minimum duration to prevent the emergence of resistant bacteria. Additionally, before using this drug, thoroughly check for a history of allergies to prevent severe reactions.
Shock, urticaria, severe swelling (edema), tightness in the chest, difficulty breathing, anaphylactic symptoms (generalized flushing, swelling, difficulty breathing, angioedema, sensory disturbances, fainting, hypertension, vasodilation), Stevens-Johnson syndrome, toxic epidermal necrolysis, agranulocytosis, granulocytopenia, pancytopenia, anemia, thrombocytopenia, aplastic anemia, hemolytic anemia, reversible neutropenia, temporary hepatitis, jaundice, AST, ALT, A
Not everyone experiences these, and they can vary from person to person.
This medication is sensitive to light, so it should be stored away from direct sunlight. It should also be kept in a tightly sealed container to avoid contact with air and stored at room temperature.
This medication is a pink syrup with a strawberry flavor that is reconstituted before use.
100g (for 150mL)/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Cefaclor Hydrate 3.75g
Syrup · Prescription medication
Jinyang Pharmaceutical Co., Ltd.

Cefaclor Hydrate 250mg
Hard capsule · Prescription medication
Ildong Pharmaceutical Co., Ltd.

Cefaclor Hydrate 250mg
Hard capsule · Prescription medication
Kolon Pharmaceutical Co., Ltd.
Cefaclor Hydrate 3.75g
Syrup · Prescription medication
Youngjin Pharmaceutical Co., Ltd.

Cefaclor Hydrate 250mg
Hard capsule · Prescription medication
Shinil Pharmaceutical Co., Ltd.

Cefaclor Hydrate 250mg
Hard capsule · Prescription medication
Hanmi Pharmaceutical Co., Ltd.
Cefaclor Hydrate 2.5g
Syrup · Prescription medication
Hanmi Pharmaceutical Co., Ltd.
Cefaclor Hydrate 3.75g
Syrup · Prescription medication
Shinpoong Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.